These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 22545680)

  • 1. Vascular memory: can we broaden the concept of the metabolic memory?
    Jermendy G
    Cardiovasc Diabetol; 2012 Apr; 11():44. PubMed ID: 22545680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New approaches in the intensive management of cardiovascular risk in the metabolic syndrome.
    Rosenson RS
    Curr Probl Cardiol; 2005 May; 30(5):241-79. PubMed ID: 15829899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The metabolic syndrome].
    Internist (Berl); 1995 May; 36(5 Suppl Metabolisc):1-12. PubMed ID: 9403089
    [No Abstract]   [Full Text] [Related]  

  • 4. Age- and gender-specific awareness, treatment, and control of cardiovascular risk factors and subclinical vascular lesions in a founder population: the SardiNIA Study.
    Scuteri A; Najjar SS; Orru' M; Albai G; Strait J; Tarasov KV; Piras MG; Cao A; Schlessinger D; Uda M; Lakatta EG
    Nutr Metab Cardiovasc Dis; 2009 Oct; 19(8):532-41. PubMed ID: 19321325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (8) Cardiovascular disease and risk management.
    American Diabetes Association
    Diabetes Care; 2015 Jan; 38 Suppl():S49-57. PubMed ID: 25537708
    [No Abstract]   [Full Text] [Related]  

  • 6. The metabolic syndrome: definition, diagnosis and management.
    Novo S; Balbarini A; Belch JJ; Bonura F; Clement DL; Diamantopoulos E; Fareed J; Norgren L; Poredos P; Rotzocil K; ; ;
    Int Angiol; 2008 Jun; 27(3):220-31. PubMed ID: 18506125
    [No Abstract]   [Full Text] [Related]  

  • 7. Targeting the consequences of the metabolic syndrome in the Diabetes Prevention Program.
    Goldberg RB; Mather K
    Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2077-90. PubMed ID: 22895669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of Dyslipidemia in Patients with Hypertension, Diabetes, and Metabolic Syndrome.
    Srikanth S; Deedwania P
    Curr Hypertens Rep; 2016 Oct; 18(10):76. PubMed ID: 27730495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solvay addresses unmet needs in the management of hypertensive patients with cardiometabolic and lipid disorders.
    Cardiovasc J Afr; 2009; 20(1):73-4. PubMed ID: 19287821
    [No Abstract]   [Full Text] [Related]  

  • 10. Management of type 2 diabetes mellitus and cardiovascular risk: lessons from intervention trials.
    Yki-Järvinen H
    Drugs; 2000 Nov; 60(5):975-83. PubMed ID: 11129129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lifestyle Changes in Relation to Initiation of Antihypertensive and Lipid-Lowering Medication: A Cohort Study.
    Korhonen MJ; Pentti J; Hartikainen J; Ilomäki J; Setoguchi S; Liew D; Kivimäki M; Vahtera J
    J Am Heart Assoc; 2020 Feb; 9(4):e014168. PubMed ID: 32019405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.
    Nesto RW
    Am J Cardiovasc Drugs; 2005; 5(6):379-87. PubMed ID: 16259526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and Validation of a Model to Predict Absolute Vascular Risk Reduction by Moderate-Intensity Statin Therapy in Individual Patients With Type 2 Diabetes Mellitus: The Anglo Scandinavian Cardiac Outcomes Trial, Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial, and Collaborative Atorvastatin Diabetes Study.
    Kaasenbrood L; Poulter NR; Sever PS; Colhoun HM; Livingstone SJ; Boekholdt SM; Pressel SL; Davis BR; van der Graaf Y; Visseren FL;
    Circ Cardiovasc Qual Outcomes; 2016 May; 9(3):213-21. PubMed ID: 27174798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined antihypertensive and statin therapy for the prevention of cardiovascular events in patients with hypertension without complications: protocol for a systematic review and meta-analysis.
    Wang Y; Kuang ZM; Feng SJ; Jiang L; Chen QX; Ji XY; Cheng WL; Hu HJ
    BMJ Open; 2018 May; 8(5):e019719. PubMed ID: 29858408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [News in the treatment of hypertension and dyslipidemia].
    Václavík J
    Vnitr Lek; 2017; 63(5):333-337. PubMed ID: 28726432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk Factor Control in Stroke Survivors with Diagnosed and Undiagnosed Diabetes: A Ghanaian Registry Analysis.
    Sarfo FS; Akassi J; Agyei M; Kontoh S; Ovbiagele B
    J Stroke Cerebrovasc Dis; 2020 Dec; 29(12):105304. PubMed ID: 32992189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secondary prevention advices after cardiovascular index event: From drug prescription to risk factors control in real world practice.
    Faggiano P; Fattirolli F; Frisinghelli A; Piccioli L; Dasseni N; Silverii MV; Albricci L; D'Ambrosio G; Garrì R; Esposito L; Giallauria F
    Monaldi Arch Chest Dis; 2019 May; 89(2):. PubMed ID: 31107039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction in cardiovascular risk using a proactive multifactorial intervention is consistent among patients residing in Pacific Asian and non-Pacific Asian regions: a CRUCIAL trial subanalysis.
    Cho EJ; Kim JH; Sutradhar S; Yunis C; Westergaard M;
    Vasc Health Risk Manag; 2014; 10():145-56. PubMed ID: 24707184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Changes in Medication Use and Adherence With Accountable Care Organization Exposure in Patients With Cardiovascular Disease or Diabetes.
    McWilliams JM; Najafzadeh M; Shrank WH; Polinski JM
    JAMA Cardiol; 2017 Sep; 2(9):1019-1023. PubMed ID: 28700790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular disease and lipids in diabetes.
    Garber AJ
    Med Clin North Am; 1998 Jul; 82(4):931-48. PubMed ID: 9706127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.